Gastrointestinal lymphoma

Summary

Gastrointestinal lymphoma (MONDO:0004699) is a cancer (an umbrella term covering 10 Mondo subtypes) and 1 clinical trial. A subtype of digestive system cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 10 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gastrointestinal lymphoma
Mondo ID	MONDO:0004699
DOID	DOID:903
NCIT	C38162
SNOMED CT	449072004
UMLS	C0740372
MedGen	148147
GARD	0024090
Anatomy (UBERON)	UBERON:0001007
Is cancer (heuristic)	yes

Also known as: digestive system lymphoma · gastrointestinal lymphoma · lymphoma of digestive system · primary digestive system lymphoma · primary gastrointestinal lymphoma

Disease family

This is a subtype of digestive system cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › gastrointestinal lymphoma

Related subtypes (14): gastric cancer, jaw cancer, liver cancer, gallbladder cancer, oral cavity cancer, pharynx cancer, intestinal cancer, spleen cancer, digestive system carcinoma, esophageal cancer, malignant pancreatic neoplasm, malignant tumor of floor of mouth, digestive system melanoma, gastroesophageal cancer

Subtypes (10): gastric lymphoma, esophagus lymphoma, small intestine lymphoma, pancreas lymphoma, splenic manifestation of prolymphocytic leukemia, splenic manifestation of hairy cell leukemia, gallbladder lymphoma, liver lymphoma, colorectal lymphoma, tonsillar lymphoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03930043	Not specified	UNKNOWN	A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin’s Lymphoma Patients